So the markets are tanking on new variant news. $NVAX just might save the day with protein based, long lasting, more efficient vax that doesn't require esoteric storage and logistical conditions. So what's next? Well..
$NVAX EU EMA Presentation 11/25/21 - EMA chief said the Final assessment of the Novavax Rolling review was completed on 11/17/21
The EU APPROVAL is imminent. The EU EMA Head Marco Calveri presented to the ECDC/EU Commission at 49:40 of the video ".. AND YOU KNOW NOVAVAX .. WE ARE NOW IN THE FINAL PHASE AND WE OUGHT TO CONCLUDE FOR AN AUTHORIZATION AS SOON AS POSSIBLE. "
https://audiovisual.ec.europa.eu/embed/index.html?ref=I-214515&lg=en
$NVAX Expecting UK Approval anytime - The Guardian today:
WHO certifying vaccine produced by SII.
$NVAX Novavax pending approvals:
Approval news could hit anytime: India UK Australia Canada EU New Zealand WHO Singapore
APPROVED: Philippines Indonesia
Moreover, current price $200.07 sits on 200 SMA, rocket is on the launch pad and has begun the count down. Currently 11% of the float is shorted which will proved additional thrust when approvals start flooding in.
Im Long since August and I have experienced a blizzard of dickslaps from the stepmarket, but the payday has arrived.
Submitted November 26, 2021 at 09:11AM by VonDerBerg https://ift.tt/3p1tyyH
